secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-07-09T13:31:32+00:00
Accession:  0001193125-26-299290
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics appoints former NASA astronaut Kathleen Rubins to board; director Matt Link resigns
--------------------------------------------------------------------------------

- Matt Link resigned from the board effective July 2, 2026.
- Kathleen Rubins appointed as Class III director effective July 8, 2026, term until 2029 annual meeting.
- Rubins also appointed to Audit, Compensation, and Governance Committees.
- Rubins is a retired NASA astronaut, microbiologist, and founding director of Trivedi Institute at University of Pittsburgh.
- She previously served on FibroBiologics' Scientific Advisory Board since 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526299290/0001193125-26-299290-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526299290/fblg-20260702.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-299290

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer